Thursday - December 26, 2024

Treatment of Cancer Using Chimeric Antigen Receptor and Protein Kinase a Blocker

2024-10-29

ALEXANDRIA, Virginia, Oct. 29 -- NOVARTIS AG, Basel, Switzerland has been assigned a patent (No. US 12128069 B2, initially filed April 22, 2016) developed by Steven M. Albelda, Philadelphia, Pennsylvania, for "Treatment of cancer using chimeric antigen receptor and protein kinase a blocker." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Treatment of Cancer Using Chimeric Antigen Receptor and Protein Kinase a Blocker

Information Request Form

Copyright Targeted News Service 2024